Recipharm joins the AMR Industry Alliance

Global contract development and manufacturing organisation (CDMO) Recipharm has joined the AMR Industry Alliance to help tackle growing concerns around antimicrobial resistance (AMR).

Recipharm joins over 100 members of the AMR Industry Alliance which was set up to provide sustainable solutions to stem AMR. It operates by facilitating collaboration between biotechnology, diagnostics, generics and pharmaceutical research organisations and associations and by informing external stakeholders about new developments in the field of AMR.

Erik Haeffler, VP of Manufacturing Services and Head of Sustainability at Recipharm said: “AMR is currently one of the most serious health concerns worldwide. At Recipharm, we manufacture antibiotics in Sweden, Italy and India so it’s important that we get involved in developing solutions to combat AMR. Joining the AMR Industry Alliance was the next natural step for us to take our work on AMR to the next level and allow us to engage with other stakeholders on the subject.”

Recipharm’s membership is the latest of the company’s initiatives focused on AMR. The company recently partnered on the multisector collaboration platform, PLATINEA, led by Uppsala University designed to find ways to preserve and enhance the value of existing antibiotics.

Steve Brooks, chair of the Manufacturing Working Group at the AMR Industry Alliance said: “We welcome Recipharm as a new member of the alliance. In recent years we’ve seen more and more companies recognising and addressing AMR and we’re delighted to see a leading CDMO like Recipharm committing to the objectives of the AMR Industry Alliance, including minimizing antibiotic emissions from the manufacturing supply chain”.

“In addition to allowing us to further explore solutions to AMR, the alliance also presents us with a framework for reducing the environmental risk of manufacturing antibiotics using risk assessments and a list of science-driven discharge concentration targets.We’re confident the alliance will allow us to continue working with experts in the field of AMR and take positive steps towards developing potential solutions,” Haeffler added.